|
|
Tennessee/NW Georgia Chapter of the National Alliance for Medication Assisted Recovery And we believe in the 5 goals of NAMA-R: To eliminate discrimination toward methadone patients. To create a more positive image about methadone maintenance treatment. To help preserve patient’s dignity and their rights. To make treatment available on demand to every person who needs…
American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Session: Organizational Meeting April 15, 2003 Picture Essay of NAMA’s Organizational Meeting Starting the Meeting Joyce calls the meeting to order. Top (l-r) Robert Sanders (NYC NAMA), Becki Ballard (OK NAMA), Gary Nessenbaum (WAMM), Jennifer Nelson Connelly (PA NAMA), Joycelyn Woods,…
HCV Info Fact 24 August 2003 The risk factors for Hepatitis C Virus infection are: Intravenous drug use- Current or remote intravenous drug use accounts for 50% of new cases of HVC; 50% to 60% infected with HCV within 3 months of initiation of injection behavior Intranasal cocaine- Risk factor suggested by epidemiologic evidence Tattooing…
For years it had been suspected that opiates had specificbinding sites in the brain. There were several attempts tolocate these sites, but the existing technologies were unable todistinguish between the non specific binding to tissue and thespecific binding to receptors. It must be mentioned here thatthe first attempt to actually measure specific opiate bindingwas in…
The Reception 40 Years Wow It’s hard to believe… Dr. Tom Payte the Conference Chair (a CMA too) cuts the cake while Mark Parrino Director of AATOD looks on with a big smile. Walter Talks PSCEP with Yvette Torres The reception is a great place to network so Walter Ginter (Vice President) finds Yvette Torres…
Policy Statement Number 9 August 2002 There are many misperceptions and misunderstanding about the federal regulations and particularly when it comes to issues regarding raising the dose over 100 mgs. Prior to the HIV epidemic in order to raise a patient’s dose it was required for the physician to contact the Food and Drug Administration…